Cargando…
Intravenous veterinary ivermectin in a COVID-19 patient causing neurotoxicity
Ivermectin administration for Coronavirus disease 2019 (COVID-19) infection has gained a lot of attention recently. Although ivermectin has a relatively good safety profile, serious adverse events may occur in patients given doses that are presumed experimental. Ivermectin for human use is available...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818555/ https://www.ncbi.nlm.nih.gov/pubmed/35155125 http://dx.doi.org/10.1016/j.idcr.2022.e01446 |